|
Advocacy Advisory Committee TOR
Dear Partners,
Notice of Disbandment of the ACSM Working Group (ACSM-WG) Call for Nominations of Advocacy Experts to the new Advocacy Advisory Committee
One of the recommendations of the recent McKinsey Evaluation of our Partnership was that overlap of function between the ACSM-WG and the Secretariat over advocacy activity should be clearer. This led to much deliberation over recent months and at its recent meeting in Tanzania, the Coordinating Board decided that:
- The ACSM-WG should be disbanded and replaced as follows:
- The old Country-level Sub-Group should be moved to become the ACSM Sub-Group of the DOTS Expansion WG where it will be appropriately linked with other TB control implementation concerns.
- The old Global Advocacy Sub-Group should be replaced by a small, expert, Advocacy Advisory Committee providing advice and support direct to the Board and the Secretariat.
This note and the attached Terms of Reference (ToR) relate to implementation of the new Committee. The formal decision of the Board is attached to the ToR, giving a fuller description of the functions and activities of this new Committee of the Board.
The Advocacy Advisory Committee will give greater impetus to advocacy activities of the whole Partnership by both advising the Board and Secretariat, and helping them to engage the broad range of Partners in TB advocacy.
For the latter purpose, the Secretariat will manage an Advocacy Network of interested Partners to facilitate linkages between TB advocates, the Stop TB Partnership, its Working Groups and its Partners. The Network will aim to do this through: better coordination of advocacy campaigns; guiding efforts through a calendar of prioritized events; and helping develop tools for enhancing resource mobilization capacity. Apart from normal contacts, there will be a physical meeting once a year.
Nominate Candidates to join the Advocacy Advisory Committee:
Partners are invited to nominate individuals whether from their own organization or elsewhere whom they believe fit the criteria for this expert Advocacy Advisory Committee. Nominations should be accompanied by a CV and a cover letter explaining the nominee's interest in and suitability for being a member of the Committee. All nominations and materials must be sent to the Stop TB Partnership Secretariat by 09 January 2009.
All nominations should be sent via email to: stoptbacsm@who.int with the following subject heading: NOMINATION FOR ADVOCACY ADVISORY COMMITEE
Queries can be addressed by email or telephone to L. Homero Hernandez: hernandezh@who.int +41-22-791-1278.
With best wishes,
Marcos Espinal, Executive Secretary, Stop TB Partnership
Paul Sommerfeld, Outgoing Chair, ACSM-WG
The Global Advocacy Sub-Group Core Group will hold its annual meeting at the Hotel du Ministères on Wednesday 15th of October 2008. The Country-Level Core Group will hold joint sessions during part of the day, but most of the time will be dedicated to working on each group's separate agendas and plans for 2009. Below are the agendas for both the joint and separate sessions of the Core Groups.
Advocacy Core Group Meeting Draft Agenda Oct 15 2008
ACSM joint Core Groups Meeting Draft Agenda Oct 15 2008
For information on how to get to the Hotel, please click on the link for the Hotel's directions and website:
http://www.ministerehotel.com/us/page4.html
For finding the best way to get to the hotel by public transport, please visit the RATP website by clicking the link below:
http://www.ratp.fr/

Launch of the Centre for Resource Mobilization website
The Global Advocacy Sub-Group announces the launch of the Centre for Resource Mobilization website. This new tool is designed as a one-stop shop for advocates and partners to take part in sharing information, experiences and intelligence for resource mobilization. The Knowledge Exchange section is designed to be an interactive vehicle for engaging partners in their efforts to learn and teach one another by sharing their tools and experiences. Please click on the banner above to visit the website.
Message from Paul Sommerfeld, ACSM Working Group Chair, World TB Day 2007

This past year, the Stop TB Partnership's ACSM Working Group made changes, especially on the global advocacy side, to make our structure more 'fit for purpose'. Now our focus is moving from structure to action.
The Partnership's latest estimate (Global TB Control Report, March 2007) is that the funding gap for TB worldwide in 2007 is around $1.1 billion. That is a massive amount, but nonetheless a big improvement on the $3.1 billion annual gap foreseen at the time of publication of the Global Plan to Stop TB 2006-2015 a little over a year ago. The report also indicates that the global TB epidemic appears to be leveling off.
Much is beginning to happen through the Global Advocacy for Resource Mobilization Task Forces (TF) - one of the main outcomes of last year's re-structuring was creation of a range of these, seen as an effective way to focus work and draw in a range of activists. The first workplans have been completed and will be sent to you shortly for your information and action.
Complementing global advocacy efforts is a robust plan of action for ACSM at country-level. National programmes recognize that community engagement is crucial to effective awareness of TB symptoms, case detection and access to treatment, as well as being essential to programmes that are supported by the government and population within which they operate.
In addition, the Challenge Facility for Civil Society (CFCS) has now been set up as a mechanism to provide financial support to small groups of civil society organizations and for funding advocacy and social mobilization activities at the grass roots level.
The message to be drawn is that advocacy is working but there is a long way to go. However, I am confident that the ACSM-WG will make a significant contribution to denting the $1.1 billion annual gap in the resources needed for effective TB work globally; as well as to improving case detection and treatment adherence, decreasing stigma and empowering people affected by TB at the country level.
I wish you every success with your efforts on World TB Day and look forward to continued collaboration during the rest of 2007.
Paul Sommerfeld
Chair, ACSM Working Group
|
[Apr-16-2007] African countries should allocate sufficient funds and implement appropriate policies to achieve the U.N. Millennium Development Goals, which include targets to reduce HIV/AIDS, tuberculosis and malaria, advocates said last week, Inter Press Service reports. Representatives from 143 member organizations of the African Civil Society Coalition on HIV/AIDS and Allies at the summit of African Union health ministers in Johannesburg, South Africa, urged African governments to set aside 15% of their national budgets for health care, as well as engage civil society and ministers to mobilize resources to combat TB. Countries also should aim during the next 10 years to bridge the funding gap for TB control of almost $11 billion, the coalition said. "We cannot meet the MDGs at this pace," Regis Mtutu of the Treatment Action Campaign said, adding, "We need to double up our efforts through some extraordinary work, particularly in the areas of HIV/AIDS, TB and malaria." The coalition presented a petition with the recommendations to the A.U. commission for health (Nduru, Inter Press Service, 3/12).
The Lancet (www.thelancet.com)
We read with interest the International Standards for Tuberculosis Care (ISTC) published in the November, 2006 issue of The Lancet Infectious Diseases (1). Focusing primarily on essential activities that all practitioners - public and private- should endorse regarding the management of patients diagnosed with suspected or confirmed tuberculosis, the ISTC brings to the forefront the responsibilities of all providers in delivering quality care to their patients. However, of equal interest is the recent publication of The Patients Charter for Tuberculosis Care (2) which addresses the rights and responsibilities of patients diagnosed with tuberculosis and which was developed in tandem with the ISTC. ...
 Action for Global Health has been started simultaneously in Brussels, France, Germany, Italy, Spain and the UK. They are monitoring how the actions and policies of European governments affect health in developing countries. They are inviting other NGOs and civil society organisations to join with them to build a European campaign to ensure that governments, the private sector and European institutions fulfil the promises they have made to reduce the rates of infant and maternal mortality and slowing down the spread of transmissible diseases in the world's poorest countries. To find out more click the link above.
Bulletin of the World Health Organization
 Special theme: tuberculosis control; Promising new tools for prevention, detection and cure; How reliable are the data?; The Global Drugs Facility; Barriers to completing treatment; Russian region reports progress; Public health classic: lessons from the past; Interview: Jorge Sampaio, UN special envoy to Stop TB
Global map reveals XDR-TB cases
 This month, WHO Stop TB launches a global map illustrating countries where XDR-TB has been confirmed, to coincide with preparations for countries to carry out rapid surveys of drug-resistance, as recommended by the WHO Global Task Force on XDR-TB in October 2006. The surveys will estimate the extent of XDR-TB within at-risk populations, and indicate whether further investigations are required. Laboratory capacity is being strengthened as part of the surveillance strategy, to ensure patients will have improved access to diagnosis and treatment of drug-resistant TB.
UNAIDS aligning with Stop TB 1 December, Geneva
Today Dr Peter Piot, Executive Director of UNAIDS, called for a collective response to MDR and XDR-TB Read more here.
Dr Piots' speech to the Stop TB Partnership Coordinating Board
WHO Press Release, Jakarta, Indonesia 29 November 2006 - Killer diseases like tuberculosis (TB) and HIV/AIDS are often forgotten while the whole world’s attention is now focusing on new emerging and epidemic/ pandemic potential diseases. Read More
The number of ACSM Working Group members is: 281.
|